Galaxy Surfactants Limited — Q4 FY26
Galaxy Surfactants reported Q4 FY26 EBITDA of ₹122 crore, down ~10% YoY, impacted by West Asia war disruptions, raw material inflation, and logistics bottlenecks.
neutral
medium
✓ Verified against BSE filing
Indian management teams deliver on roughly 12% of specific earnings-call promises. A low score does not indicate dishonesty — it reflects how aspirational forward guidance typically is.
Q3 FY26
India specialty volume growth to remain double-digit
Management expects double-digit volume growth in the specialty segment in India, supported by new product launches and customer approvals.
Missed
Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
heuristic_v1
Q3 FY26
New reformulation products to commercialize in Q4 FY26
Alternate formulations for key tier-1 customers are under approval and expected to start commercialization in Q4 FY26.
Missed
Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
heuristic_v1
Q3 FY26
US specialty pipeline projects to restart from late Q4
With tariff reduction, customer projects put on hold are expected to resume, contributing from late Q4 FY26 and Q1 FY27.
Missed
Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
heuristic_v1